Newsroom | 49388 results

SAN DIEGO--(BUSINESS WIRE)--Travere Therapeutics, Inc. (NASDAQ: TVTX) today announced that, based on preliminary and unaudited financial data, the Company expects total U.S. net product sales for the fourth quarter of 2025 to be approximately $127 million. For the fiscal year 2025, the Company expects total U.S. net product sales to be approximately $410 million. The Company ended 2025 with approximately $323 million in cash, cash equivalents, and marketable securities. The Company also provide...

BOSTON--(BUSINESS WIRE)--Verastem Oncology (Nasdaq: VSTM), a biopharmaceutical company committed to advancing new medicines for patients with RAS/MAPK pathway-driven cancers, today announced the grant of stock options to purchase 73,000 shares of its common stock to eight new employees and the grant of 218,265 restricted stock units to nineteen new employees. The awards were granted pursuant to the Nasdaq inducement grant exception as an inducement material to the employee’s acceptance of emplo...

LEXINGTON, Mass.--(BUSINESS WIRE)--Agenus Inc. (Nasdaq: AGEN), azienda leader nell'innovazione immuno-oncologica, oggi ha annunciato che l'Agenzia nazionale per la sicurezza dei medicinali e dei prodotti sanitari (ANSM) francese ha approvato un protocollo terapeutico nazionale aggiornato per botensilimab (BOT) in combinazione con balstilimab (BAL) nell'ambito dell'Autorizzazione all'accesso per uso compassionevole (AAC) francese. Il protocollo aggiornato estende l'autorizzazione francese AAC pr...

DARMSTADT, Germany--(BUSINESS WIRE)--FDA Accepts New Drug Application for Pimicotinib for the Treatment of Tenosynovial Giant Cell Tumor...

SAN FRANCISCO--(BUSINESS WIRE)--PVP Labs, a biotechnology company advancing next-generation peptide-based therapeutics, today announced its participation in the JP Morgan Healthcare Conference 2026, where the company will engage with institutional investors and strategic partners to present its leading product, TAPHALGIN®, an innovative, non-addictive analgesic platform. TAPHALGIN® is a first-in-class tetrapeptide analgesic engineered to deliver rapid, clinically meaningful pain relief while av...

EINDHOVEN, Pays-Bas--(BUSINESS WIRE)--Onera Health, un chef de file de la transformation de la médecine du sommeil, vient d’annoncer la parution récente des résultats d’une étude de validation multicentrique portant sur son dispositif Onera Sleep Test System (STS) dans la revue scientifique en libre accès ERJ Open Research, publiée par la Société européenne des maladies respiratoires (European Respiratory Society, ERS). Il s’agit de la deuxième publication issue de cette étude, et celle-ci démo...

EINDHOVEN, Nederland--(BUSINESS WIRE)--Onera Health, een leider in het transformeren van slaapgeneeskunde, kondigt de recente publicatie aan van een multicenter valideringsstudie van haar Onera STS (Sleep Test System) in de ERJ Open Research, een toonaangevend wetenschappelijk tijdschrift met volledig open toegang, uitgegeven door de ESR (European Respiratory Society). Dit is de tweede publicatie van deze studie, die aantoont dat het Onera STS-apparaat op basis van patches voor hPSG (home-polys...

EINDHOVEN, Países Bajos--(BUSINESS WIRE)--Onera Health, líder en la transformación de la medicina del sueño, anuncia la reciente publicación de un estudio de validación multicéntrico de su Onera Sleep Test System (STS) en ERJ Open Research, una destacada revista científica de acceso abierto publicada por la European Respiratory Society (ERS). La segunda publicación derivada de este estudio demuestra que el dispositivo de polisomnografía domiciliaria basado en parches Onera STS identifica con pr...

EINDHOVEN, Paesi Bassi--(BUSINESS WIRE)--Onera Health, azienda leader nella trasformazione della medicina del sonno, annuncia la recente pubblicazione di uno studio multicentrico di convalida del suo Onera Sleep Test System (STS, sistema di esame del sonno) nell'ERJ Open Research, importante rivista scientifica totalmente ad accesso aperto pubblicata dalla European Respiratory Society (ERS). Si tratta della seconda pubblicazione da questo studio, e dimostra che il dispositivo di polisonnografia...

EINDHOVEN, Niederlande--(BUSINESS WIRE)--Onera Health, ein Marktführer für Innovationen auf dem Gebiet der Schlafmedizin, hat die kürzlich erfolgte Veröffentlichung einer multizentrischen Validierungsstudie seines Onera Sleep Test Systems (STS) in ERJ Open Research bekannt gegeben, einer führenden, vollständig frei zugänglichen wissenschaftlichen Fachzeitschrift, die von der European Respiratory Society (ERS) herausgegeben wird. Es handelt sich hierbei um die zweite Veröffentlichung aus dieser...